Yuesong Wu
Overview
Explore the profile of Yuesong Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Su H, Wu Y, Chen B, Cui Y
Nat Commun
. 2025 Feb;
16(1):1793.
PMID: 39979358
One of the major challenges in spatial transcriptomics is to detect spatially variable genes (SVGs), whose expression patterns are non-random across tissue locations. Many SVGs correlate with cell type compositions,...
2.
Taner H, Gong W, Fitzsimonds Z, Li Z, Wu Y, He Y, et al.
bioRxiv
. 2024 Dec;
PMID: 39713429
Squamous cell carcinomas (SCC) are often preceded by potentially malignant precursor lesions, most of which remain benign. The terminal exhaustion phenotypes of effector T-cells and the accumulation of myeloid-derived suppressor...
3.
Loveless I, Kemp S, Hartway K, Mitchell J, Wu Y, Zwernik S, et al.
Clin Cancer Res
. 2024 Dec;
31(4):756-772.
PMID: 39636224
Purpose: Pancreatic ductal adenocarcinoma (PDAC) patients with tumors enriched for the basal-like molecular subtype exhibit enhanced resistance to standard-of-care treatments and have significantly worse overall survival compared with patients with...
4.
Lv C, Xu J, Pan T, Shi W, Zhang W, Wu Y, et al.
Int J Biol Macromol
. 2024 Oct;
282(Pt 3):136874.
PMID: 39476908
This paper investigated the interaction between leptosidin, an aurone-based derivative and a subset of the flavone family, and transferrin using a variety of spectroscopic, molecular docking, and molecular dynamic investigations....
5.
Zhou J, Wan S, Wu Y, Hu H, Liu Y, Liao Z, et al.
Biomed Pharmacother
. 2024 Jul;
177:117102.
PMID: 38991303
Paclitaxel (PTX) is a first-line drug for the treatment of lung cancer, but its targeting and therapeutic effect are unsatisfactory. Herein, lung cancer cell (A549) membrane biomimetic PTX-loaded poly (lactic-co-glycolic...
6.
Wu Y, Fan Q, Zhou J, Hu H, Liao Z, Tang X, et al.
Colloids Surf B Biointerfaces
. 2024 May;
240:113973.
PMID: 38795584
Curcumin (CUR) is a promising natural product for hepatocellular carcinoma (HCC) therapy. However, its clinical application has been limited by some issues such as rapid clearance and inadequate tumor accumulation....
7.
Mo B, Luo B, Wu Y
Am J Transl Res
. 2024 Feb;
16(1):12-26.
PMID: 38322570
Objectives: Cancer has emerged as a global issue in terms of public health care and treatment. The significance of calcyclin binding protein () in various neoplasms suggests that it may...
8.
Byrnes N, Wu Y, Nolvachai Y, Marriott P
J Chromatogr A
. 2023 Sep;
1708:464369.
PMID: 37714012
This study aims to assess and qualitatively compare the visual presentation of chromatographic data from the isomerisation of natural pyrethrins - a group of pesticides derived from Chrysanthemum flowers -...
9.
Lai J, Li Y, Ran M, Huang Q, Huang F, Zhu L, et al.
Biomed Pharmacother
. 2023 May;
163:114811.
PMID: 37156117
Background: Thrombocytopenia is a common hematological disease caused by many factors. It usually complicates critical diseases and increases morbidity and mortality. The treatment of thrombocytopenia remains a great challenge in...
10.
Heath B, Gong W, Taner H, Broses L, Okuyama K, Cheng W, et al.
Cell Rep
. 2023 Mar;
42(4):112303.
PMID: 36952341
Oncogenes destabilize STING in epithelial cell-derived cancer cells, such as head and neck squamous cell carcinomas (HNSCCs), to promote immune escape. Despite the abundance of tumor-infiltrating myeloid cells, HNSCC presents...